Cargando…

Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model

BACKGROUND: Advancing female age remains a difficult problem in infertility treatment. Ovarian angiogenesis plays an important role in follicular development and the activation of ovarian angiogenesis has been emerged as a new strategy for the improvement of age-related decline of oocyte quality. BM...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Seung S, Park, Min J, Joo, Bo S, Joo, Jong K, Son, Jung B, Lee, Kyu S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551793/
https://www.ncbi.nlm.nih.gov/pubmed/23273273
http://dx.doi.org/10.1186/1477-7827-10-117
_version_ 1782256617488646144
author Park, Seung S
Park, Min J
Joo, Bo S
Joo, Jong K
Son, Jung B
Lee, Kyu S
author_facet Park, Seung S
Park, Min J
Joo, Bo S
Joo, Jong K
Son, Jung B
Lee, Kyu S
author_sort Park, Seung S
collection PubMed
description BACKGROUND: Advancing female age remains a difficult problem in infertility treatment. Ovarian angiogenesis plays an important role in follicular development and the activation of ovarian angiogenesis has been emerged as a new strategy for the improvement of age-related decline of oocyte quality. BMP-6 affect gonadotropin signals in granulosa cells and it promotes normal fertility by enabling appropriate response to LH and normal oocyte quality. BMP-6 has a potential role in regulation of angiogenesis and regulates the expression of inhibitor of DNA-binding proteins (Ids). Ids involved in the control and timing of follicle selection and granulosa cells differentiation. Especially, Id-1 is well-characterized target of BMP-6 signaling. Therefore, this study investigated whether co-administration of BMP-6 during superovulation process improves ovarian response, oocyte quality and expression of Id-1 and vascular endothelial growth factor (VEGF) in the ovary of aged female using a mouse model. METHODS: Aged C57BL/6 female mice (26–31 weeks old) were superovulated by injection with 0.1 mL of 5 IU equine chorionic gonadotropin (eCG) containing recombinant mouse BMP-6 at various doses (0, 0.01, 0.1, 1, and 10 ng), followed by injection with 5 IU human chorionic gonadotropin (hCG) 48 h later. Then, the mice were immediately paired with an individual male. The aged control group was superovulated without BMP-6. Young mice of 6–9 weeks old were superovulated without BMP-6 as a positive control for superovulation and in vitro culture of embryos. Eighteen hours after hCG injection, zygotes were retrieved and cultured for 4 days. Both ovaries of each mouse were provided in the examination of ovarian expression of Id-1 and VEGF by reverse transcriptase-polymerase chain reaction, western blot, and immunohistochemistry. RESULTS: Administration of 0.1 ng BMP-6 significantly increased the number and blastocyst formation rate of oocytes ovulated and ovarian expression of Id-1 and VEGF compared to aged control mice. These increased levels were comparable to those of young control mice. CONCLUSIONS: This result suggests that BMP-6 during ovulation induction plays an important role in improvement of oocyte quality and ovarian response of aged female, possibly by regulating of ovarian Id-1 and VEGF expression.
format Online
Article
Text
id pubmed-3551793
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-35517932013-01-24 Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model Park, Seung S Park, Min J Joo, Bo S Joo, Jong K Son, Jung B Lee, Kyu S Reprod Biol Endocrinol Research BACKGROUND: Advancing female age remains a difficult problem in infertility treatment. Ovarian angiogenesis plays an important role in follicular development and the activation of ovarian angiogenesis has been emerged as a new strategy for the improvement of age-related decline of oocyte quality. BMP-6 affect gonadotropin signals in granulosa cells and it promotes normal fertility by enabling appropriate response to LH and normal oocyte quality. BMP-6 has a potential role in regulation of angiogenesis and regulates the expression of inhibitor of DNA-binding proteins (Ids). Ids involved in the control and timing of follicle selection and granulosa cells differentiation. Especially, Id-1 is well-characterized target of BMP-6 signaling. Therefore, this study investigated whether co-administration of BMP-6 during superovulation process improves ovarian response, oocyte quality and expression of Id-1 and vascular endothelial growth factor (VEGF) in the ovary of aged female using a mouse model. METHODS: Aged C57BL/6 female mice (26–31 weeks old) were superovulated by injection with 0.1 mL of 5 IU equine chorionic gonadotropin (eCG) containing recombinant mouse BMP-6 at various doses (0, 0.01, 0.1, 1, and 10 ng), followed by injection with 5 IU human chorionic gonadotropin (hCG) 48 h later. Then, the mice were immediately paired with an individual male. The aged control group was superovulated without BMP-6. Young mice of 6–9 weeks old were superovulated without BMP-6 as a positive control for superovulation and in vitro culture of embryos. Eighteen hours after hCG injection, zygotes were retrieved and cultured for 4 days. Both ovaries of each mouse were provided in the examination of ovarian expression of Id-1 and VEGF by reverse transcriptase-polymerase chain reaction, western blot, and immunohistochemistry. RESULTS: Administration of 0.1 ng BMP-6 significantly increased the number and blastocyst formation rate of oocytes ovulated and ovarian expression of Id-1 and VEGF compared to aged control mice. These increased levels were comparable to those of young control mice. CONCLUSIONS: This result suggests that BMP-6 during ovulation induction plays an important role in improvement of oocyte quality and ovarian response of aged female, possibly by regulating of ovarian Id-1 and VEGF expression. BioMed Central 2012-12-29 /pmc/articles/PMC3551793/ /pubmed/23273273 http://dx.doi.org/10.1186/1477-7827-10-117 Text en Copyright ©2012 Park et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Park, Seung S
Park, Min J
Joo, Bo S
Joo, Jong K
Son, Jung B
Lee, Kyu S
Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model
title Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model
title_full Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model
title_fullStr Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model
title_full_unstemmed Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model
title_short Improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model
title_sort improvement of ovarian response and oocyte quality of aged female by administration of bone morphogenetic protein-6 in a mouse model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551793/
https://www.ncbi.nlm.nih.gov/pubmed/23273273
http://dx.doi.org/10.1186/1477-7827-10-117
work_keys_str_mv AT parkseungs improvementofovarianresponseandoocytequalityofagedfemalebyadministrationofbonemorphogeneticprotein6inamousemodel
AT parkminj improvementofovarianresponseandoocytequalityofagedfemalebyadministrationofbonemorphogeneticprotein6inamousemodel
AT joobos improvementofovarianresponseandoocytequalityofagedfemalebyadministrationofbonemorphogeneticprotein6inamousemodel
AT joojongk improvementofovarianresponseandoocytequalityofagedfemalebyadministrationofbonemorphogeneticprotein6inamousemodel
AT sonjungb improvementofovarianresponseandoocytequalityofagedfemalebyadministrationofbonemorphogeneticprotein6inamousemodel
AT leekyus improvementofovarianresponseandoocytequalityofagedfemalebyadministrationofbonemorphogeneticprotein6inamousemodel